Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease

Clinical Implications of the COMPASS Trial

Stephen J. Nicholls; Adam J. Nelson

Disclosures

Am J Cardiovasc Drugs. 2019;19(4):343-348. 

In This Article

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....